Articles published by C4 Therapeutics, Inc.
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 08, 2024
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
February 22, 2024
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
January 04, 2024
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma
December 12, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 01, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Announces Chief Financial Officer Succession
September 05, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 08, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png)
![](https://ml.globenewswire.com/media/709d3e68-72e8-413a-88e2-35ced331cd3c/small/c4-logo-no-tag-061220-8-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/709d3e68-72e8-413a-88e2-35ced331cd3c/small/c4-logo-no-tag-061220-8-png.png)
![](https://ml.globenewswire.com/media/ee9ec497-16c0-474d-9487-dcaad3e580b4/small/c4-logo-no-tag-061220-png.png)
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 04, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/ee9ec497-16c0-474d-9487-dcaad3e580b4/small/c4-logo-no-tag-061220-png.png)
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/ee9ec497-16c0-474d-9487-dcaad3e580b4/small/c4-logo-no-tag-061220-png.png)
C4 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
February 23, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/ee9ec497-16c0-474d-9487-dcaad3e580b4/small/c4-logo-no-tag-061220-png.png)
C4 Therapeutics to Present at Two Virtual February 2023 Conferences
February 08, 2023
Via GlobeNewswire
Tickers
CCCC
![](https://ml.globenewswire.com/media/ee9ec497-16c0-474d-9487-dcaad3e580b4/small/c4-logo-no-tag-061220-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.